| KILITCH Stock | | | 310.65 3.25 1.06% |
Kilitch Drugs financial indicator trend analysis is infinitely more than just investigating Kilitch Drugs Limited recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kilitch Drugs Limited is a good investment. Please check the relationship between Kilitch Drugs Ebit and its Selling And Marketing Expenses accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kilitch Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Kilitch Drugs Limited Ebit account and
Selling And Marketing Expenses. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Kilitch Drugs' Ebit and Selling And Marketing Expenses is -0.36. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Selling And Marketing Expenses in the same time period over historical financial statements of Kilitch Drugs Limited, assuming nothing else is changed. The correlation between historical values of Kilitch Drugs' Ebit and Selling And Marketing Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of Kilitch Drugs Limited are associated (or correlated) with its Selling And Marketing Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling And Marketing Expenses has no effect on the direction of Ebit i.e., Kilitch Drugs' Ebit and Selling And Marketing Expenses go up and down completely randomly.
Correlation Coefficient | -0.36 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Most indicators from Kilitch Drugs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kilitch Drugs Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kilitch Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
As of now, Kilitch Drugs'
Tax Provision is increasing as compared to previous years. The Kilitch Drugs' current
Issuance Of Capital Stock is estimated to increase to about 40.5
M, while
Selling General Administrative is projected to decrease to under 25
M.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Balance Sheet is a snapshot of the
financial position of Kilitch Drugs Limited at a specified time, usually calculated after every quarter, six months, or one year. Kilitch Drugs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Kilitch Drugs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Kilitch currently owns. An asset can also be divided into two categories, current and non-current.